Top Story

Molecular surgical margin assessment may predict recurrence in head and neck cancers

Molecular surgical margin assessment may predict recurrence in head and neck cancers
May 6, 2015

A panel of gene methylation targets in deep surgical margin imprints appeared to predict postoperative locoregional recurrence in patients with postoperative recurrence in patients with head and neck squamous cell carcinoma, according to results of a prospective study.

“Intraoperative use of molecular margin imprint analysis may assist surgeons in obtaining rigorously negative surgical margins and improve the outcome of head and neck surgery,” Wayne M. Koch, MD, director of the Johns Hopkins Head and Neck Cancer Center and a professor of oncology and otolaryngology — head and neck surgery at Johns Hopkins University, and colleagues wrote.

Hispanics found to have significantly better health outcomes than whites

May 6, 2015
Representing approximately 17.7% of the U.S. population, Hispanics and Latinos have significantly lower all-cause death rates compared with whites, despite a lack of…
Abi Fisher, PhD In the Journals

Few patients with colorectal cancer receive advice on exercise

May 6, 2015
Only one-third of patients with colorectal cancer reported being advised to engage in physical activity during treatment despite evidence that exercise is linked to…
FDA News

FDA grants orphan drug designation to Reolysin for gastric cancer

May 6, 2015
The FDA granted orphan drug designation to pelareorep for the treatment of gastric cancer, the drug’s manufacturer announced today. In addition to the receipt of…
FDA News

FDA grants breakthrough therapy designation to venetoclax for CLL with 17p deletion

May 6, 2015
The FDA today granted breakthrough therapy designation to venetoclax for previously treated patients with relapsed or refractory chronic lymphocytic leukemia who harbor…
More News Headlines »
CME
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
Meeting News Coverage Video
VIDEO: Immunotherapies show promise in NSCLC, mesothelioma

VIDEO: Immunotherapies show promise in NSCLC, mesothelioma

May 1, 2015
PHILADELPHIA — Alex A. Adjei, MD, PhD, FACP, senior vice president of clinical research, professor and chair of…
More »
CME CNE
Low Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »
morganatic-roan